Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02633059 · OUTCOME

Impact of MDM2 Inhibition on Activation of p53 and Clonal Selection

Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma · Source last updated 2024-09-19

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Up to 6 months

What was measured

Impact of MDM2 inhibition on activation of p53 and clonal selection examined using gene expression profiling and exome sequencing

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denom Units Selected
Participants
description
Impact of MDM2 inhibition on activation of p53 and clonal selection examined using gene expression profiling and exome sequencing
reporting Status
NOT_POSTED
time Frame
Up to 6 months
title
Impact of MDM2 Inhibition on Activation of p53 and Clonal Selection
type
OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice